Table 7.
Comparison of pDC frequency (stratified analysis).
| Week | Group | Young participants (%) | Middle-aged participants (%) | ||
|---|---|---|---|---|---|
| Mean ± SD | p-value | Mean ± SD | p-value | ||
| 0 | Placebo | 1.22 ± 0.88 | 0.588 | 0.79 ± 0.50 | 0.505 |
| LG2055 | 1.34 ± 0.85 | 0.85 ± 0.55 | |||
| 4 | Placebo | 1.17 ± 0.58 | 0.838 | 0.82 ± 0.50 | 0.846 |
| LG2055 | 1.21 ± 0.78 | 0.84 ± 0.55 | |||
| 8 | Placebo | 0.89 ± 0.55 | 0.162 | 0.64 ± 0.38 | 0.524 |
| LG2055 | 1.18 ± 0.93 | 0.68 ± 0.38 | |||
| 12 | Placebo | 0.87 ± 0.50 | 0.871 | 0.58 ± 0.40 | 0.180 |
| LG2055 | 0.89 ± 0.52 | 0.68 ± 0.41 | |||